Inventor

AUDIA JAMES E

US79 patents

⚠️ This page may combine multiple inventors who share the name “AUDIA JAMES E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AUDIA JAMES E

LILLY CO ELI

Compounds having effects on serotonin-related systems

Compounds having effects on serotonin-related systems

Compounds having effects on serotonin-related systems

5-HT1F agonists for the treatment of migraine

3-&lt;1-alkylenearyl&gt;-4-&lt;1,2,3,6-tetrahydropyridinyl&gt;-and 3-&lt;1-alkylenearyl&gt;-4-piperidinyl-1h-indoles: new 5-HT1F agonists

Tetrahydro-beta-carbolines

5HT1F agonists for the treatment of migraine

Inhibition of serotonin reuptake

5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine

Method for treating 5HT2B receptor related conditions

Compositions for inhibiting bone loss

Treatment and prevention of prostatic cancer metastasis

8-substituted tetrahydro-beta-carbolines

Method of preventing prostatic cancer development

Methods for inhibiting bone loss

Process for the preparation of benzo (f) quinolinones

Aminoalkyl-indoles

Tetrahydro-beta carbolines

Tetrahydrobetacarboline compounds

Tetrahydro-pyrido-indole

Indole-ethanamines

Tetrahydro-beta-carbolines

Intermediates to tetrahydro-beta-carbolines

Tetrahydro-beta-carbolines

Compounds having effects on serotonin-related systems

Naphthylpiperazinyl compounds useful for treating 5HT2B receptor mediated conditions

Benzo(F)quinolinones

Tetrahydro-beta-carbolines

Tetrahydro-Beta-Carbolines

Tetrahydro-beta-carbolines

Tetrahydro-β-carbolines

Polycyclic α-amino-ε-caprolactams and related compounds

Method for treating 5-HT2B receptor related conditions

Tetrahydro-beta-carbolines

ELAN PHARM INC

Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

ATHENA NEUROSCIENCES INC

Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use

N-(aryl/heteroaryl) amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds

ALBRECHT BRIAN K

Bromodomain inhibitors and uses thereof

ELAN PHARMACEUTIALS INC

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists